Detalhe da pesquisa
1.
Syngeneic murine models with distinct immune microenvironments represent subsets of human intrahepatic cholangiocarcinoma.
J Hepatol
; 2024 Mar 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38458319
2.
Outcomes of Neoadjuvant Chemotherapy for Invasive Intraductal Papillary Mucinous Neoplasm Compared with de Novo Pancreatic Adenocarcinoma.
Ann Surg Oncol
; 31(4): 2632-2639, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38319513
3.
Value of Surgical Cytoreduction in Patients with Small Intestinal Neuroendocrine Tumors Metastatic to the Liver and Peritoneum.
Ann Surg Oncol
; 2024 Apr 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38689169
4.
Neuroendocrine Tumors of Unknown Primary in the Setting of Cytoreductive Hepatectomy.
Ann Surg Oncol
; 2024 May 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38717544
5.
The death of laparoscopy.
Surg Endosc
; 38(5): 2677-2688, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38519609
6.
Early vs conventional onset pancreatic ductal adenocarcinoma: analysis of surgical and oncologic outcomes in patients undergoing curative intent resection.
HPB (Oxford)
; 26(1): 145-153, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37752029
7.
LCK inhibition downregulates YAP activity and is therapeutic in patient-derived models of cholangiocarcinoma.
J Hepatol
; 78(1): 142-152, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36162702
8.
An APRI+ALBI Based Multivariable Model as Preoperative Predictor for Posthepatectomy Liver Failure.
Ann Surg
; 2023 Oct 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37860868
9.
Survival and Symptomatic Relief After Cytoreductive Hepatectomy for Neuroendocrine Tumor Liver Metastases: Long-Term Follow-up Evaluation of More Than 500 Patients.
Ann Surg Oncol
; 30(8): 4840-4851, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37208566
10.
Laparoscopic versus open liver resections for intrahepatic cholangiocarcinoma and gallbladder cancer: the Mayo clinic experience.
HPB (Oxford)
; 25(3): 339-346, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36707278
11.
Minimally invasive vs. open approach to the simultaneous treatment of colorectal tumors with synchronous liver metastasis: a single center, propensity-score matched analysis from Mayo clinic.
HPB (Oxford)
; 25(11): 1337-1344, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37626006
12.
Consequences of Perioperative Serotonin Reuptake Inhibitor Treatment During Hepatic Surgery.
Hepatology
; 73(5): 1956-1966, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33078426
13.
Safety and Outcomes of Combined Pancreatic and Hepatic Resections for Metastatic Pancreatic Neuroendocrine Tumors.
Ann Surg Oncol
; 29(11): 6949-6957, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-35731358
14.
Neoadjuvant Chemotherapy Switch in Borderline Resectable/Locally Advanced Pancreatic Cancer.
Ann Surg Oncol
; 29(3): 1579-1591, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34724125
15.
FDG-PET Predicts Neoadjuvant Therapy Response and Survival in Borderline Resectable/Locally Advanced Pancreatic Adenocarcinoma.
J Natl Compr Canc Netw
; 20(9): 1023-1032.e3, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-36075389
16.
Contemporary outcomes of pancreaticoduodenectomy for benign and precancerous cystic lesions.
HPB (Oxford)
; 24(9): 1416-1424, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35140056
17.
Hepatocellular carcinoma as predominant cancer subgroup accounting for sex differences in post-hepatectomy liver failure, morbidity and mortality.
HPB (Oxford)
; 24(9): 1453-1463, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35293321
18.
Outcomes of pancreatectomy with portomesenteric venous resection and reconstruction for locally advanced pancreatic neuroendocrine neoplasms.
HPB (Oxford)
; 24(7): 1186-1193, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35078716
19.
Patency rates of hepatic arterial resection and revascularization in locally advanced pancreatic cancer.
HPB (Oxford)
; 24(11): 1957-1966, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35780039
20.
Factors Predicting Response, Perioperative Outcomes, and Survival Following Total Neoadjuvant Therapy for Borderline/Locally Advanced Pancreatic Cancer.
Ann Surg
; 273(2): 341-349, 2021 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30946090